0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transdermal Patch Drug Delivery System Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-38D302
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Transdermal Patch Drug Delivery System Market Insights Forecast to 2028

Global Transdermal Patch Drug Delivery System Market Insights, Forecast to 2028

Code: QYRE-Auto-38D302
Report
February 2022
118 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Transdermal Patch Drug Delivery System Market Outlook 2022-2028

The global Transdermal Patch Drug Delivery System market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Shunt Way accounting for % of the Transdermal Patch Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

Transdermal Patch Drug Delivery System Market Analysis and Insights

Transdermal patches drug delivery system are a method of delivering drugs directly through the skin into the bloodstream.It mainly has polymer matrix, drug, penetration accelerator and adhesive layer.Patches can provide controlled, continuous administration of drugs that are easy to eat with minimal side effects and non-invasive.Compared to injectable and oral systems, it avoids first-pass metabolism and is easy to maintain drug concentration, ensuring that drugs reach the body with minimal side effects, ensuring good adhesion and effective release through the skin in the form of skin circulation for hours or days.

Transdermal Patch Drug Delivery System Market Size and Share

China Transdermal Patch Drug Delivery System market size is valued at US$ million in 2021, while the North America and Europe Transdermal Patch Drug Delivery System are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Transdermal Patch Drug Delivery System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal Patch Drug Delivery System market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal Patch Drug Delivery System market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal Patch Drug Delivery System market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal Patch Drug Delivery System market.

Transdermal Patch Drug Delivery System Market Segment and Scope

Transdermal Patch Drug Delivery System market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Patch Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Transdermal Patch Drug Delivery System Market Segment By Type

  • Shunt Way
  • Intercellular Lipid Structure Pathway
  • Trans-cellular Pathway

Transdermal Patch Drug Delivery System Market Segment By Application

  • Hospital
  • Clinic
  • Home Care
  • Other

Transdermal Patch Drug Delivery System Market By Company

  • Hisamitsu Pharmaceutical
  • Novartis
  • ProSolus
  • Tapemark
  • Tesa Labtec
  • NITTO DENKO CORPORATION
  • Noven Pharmaceuticals
  • LTS Lohmann Therapie-Systeme
  • Medherant
  • Corium
  • Antares Pharma
  • Syntropharma
  • Teikoku Pharma
  • Mylan
  • Actavis
  • Mundipharma
  • Henan Lingrui Pharmaceutical
  • Changzhou Siyao
  • Rfl Pharmaceutical

Transdermal Patch Drug Delivery System Market By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Shunt Way
1.2.3 Intercellular Lipid Structure Pathway
1.2.4 Trans-cellular Pathway
1.3 Market by Application
1.3.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Patch Drug Delivery System Market Perspective (2017-2028)
2.2 Transdermal Patch Drug Delivery System Growth Trends by Region
2.2.1 Transdermal Patch Drug Delivery System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transdermal Patch Drug Delivery System Historic Market Size by Region (2017-2022)
2.2.3 Transdermal Patch Drug Delivery System Forecasted Market Size by Region (2023-2028)
2.3 Transdermal Patch Drug Delivery System Market Dynamics
2.3.1 Transdermal Patch Drug Delivery System Industry Trends
2.3.2 Transdermal Patch Drug Delivery System Market Drivers
2.3.3 Transdermal Patch Drug Delivery System Market Challenges
2.3.4 Transdermal Patch Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue
3.1.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue (2017-2022)
3.1.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by Players (2017-2022)
3.2 Global Transdermal Patch Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Patch Drug Delivery System Revenue
3.4 Global Transdermal Patch Drug Delivery System Market Concentration Ratio
3.4.1 Global Transdermal Patch Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Patch Drug Delivery System Revenue in 2021
3.5 Transdermal Patch Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Transdermal Patch Drug Delivery System Product Solution and Service
3.7 Date of Enter into Transdermal Patch Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Patch Drug Delivery System Breakdown Data by Type
4.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Type (2017-2022)
4.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2023-2028)
5 Transdermal Patch Drug Delivery System Breakdown Data by Application
5.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Application (2017-2022)
5.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transdermal Patch Drug Delivery System Market Size (2017-2028)
6.2 North America Transdermal Patch Drug Delivery System Market Size by Type
6.2.1 North America Transdermal Patch Drug Delivery System Market Size by Type (2017-2022)
6.2.2 North America Transdermal Patch Drug Delivery System Market Size by Type (2023-2028)
6.2.3 North America Transdermal Patch Drug Delivery System Market Share by Type (2017-2028)
6.3 North America Transdermal Patch Drug Delivery System Market Size by Application
6.3.1 North America Transdermal Patch Drug Delivery System Market Size by Application (2017-2022)
6.3.2 North America Transdermal Patch Drug Delivery System Market Size by Application (2023-2028)
6.3.3 North America Transdermal Patch Drug Delivery System Market Share by Application (2017-2028)
6.4 North America Transdermal Patch Drug Delivery System Market Size by Country
6.4.1 North America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
6.4.2 North America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Transdermal Patch Drug Delivery System Market Size (2017-2028)
7.2 Europe Transdermal Patch Drug Delivery System Market Size by Type
7.2.1 Europe Transdermal Patch Drug Delivery System Market Size by Type (2017-2022)
7.2.2 Europe Transdermal Patch Drug Delivery System Market Size by Type (2023-2028)
7.2.3 Europe Transdermal Patch Drug Delivery System Market Share by Type (2017-2028)
7.3 Europe Transdermal Patch Drug Delivery System Market Size by Application
7.3.1 Europe Transdermal Patch Drug Delivery System Market Size by Application (2017-2022)
7.3.2 Europe Transdermal Patch Drug Delivery System Market Size by Application (2023-2028)
7.3.3 Europe Transdermal Patch Drug Delivery System Market Share by Application (2017-2028)
7.4 Europe Transdermal Patch Drug Delivery System Market Size by Country
7.4.1 Europe Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
7.4.2 Europe Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size (2017-2028)
8.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type
8.2.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Share by Type (2017-2028)
8.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application
8.3.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Share by Application (2017-2028)
8.4 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region
8.4.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transdermal Patch Drug Delivery System Market Size (2017-2028)
9.2 Latin America Transdermal Patch Drug Delivery System Market Size by Type
9.2.1 Latin America Transdermal Patch Drug Delivery System Market Size by Type (2017-2022)
9.2.2 Latin America Transdermal Patch Drug Delivery System Market Size by Type (2023-2028)
9.2.3 Latin America Transdermal Patch Drug Delivery System Market Share by Type (2017-2028)
9.3 Latin America Transdermal Patch Drug Delivery System Market Size by Application
9.3.1 Latin America Transdermal Patch Drug Delivery System Market Size by Application (2017-2022)
9.3.2 Latin America Transdermal Patch Drug Delivery System Market Size by Application (2023-2028)
9.3.3 Latin America Transdermal Patch Drug Delivery System Market Share by Application (2017-2028)
9.4 Latin America Transdermal Patch Drug Delivery System Market Size by Country
9.4.1 Latin America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
9.4.2 Latin America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size (2017-2028)
10.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type
10.2.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Share by Type (2017-2028)
10.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application
10.3.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Share by Application (2017-2028)
10.4 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country
10.4.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Company Details
11.1.2 Hisamitsu Pharmaceutical Business Overview
11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.1.4 Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.1.5 Hisamitsu Pharmaceutical Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Transdermal Patch Drug Delivery System Introduction
11.2.4 Novartis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 ProSolus
11.3.1 ProSolus Company Details
11.3.2 ProSolus Business Overview
11.3.3 ProSolus Transdermal Patch Drug Delivery System Introduction
11.3.4 ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.3.5 ProSolus Recent Developments
11.4 Tapemark
11.4.1 Tapemark Company Details
11.4.2 Tapemark Business Overview
11.4.3 Tapemark Transdermal Patch Drug Delivery System Introduction
11.4.4 Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.4.5 Tapemark Recent Developments
11.5 Tesa Labtec
11.5.1 Tesa Labtec Company Details
11.5.2 Tesa Labtec Business Overview
11.5.3 Tesa Labtec Transdermal Patch Drug Delivery System Introduction
11.5.4 Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.5.5 Tesa Labtec Recent Developments
11.6 NITTO DENKO CORPORATION
11.6.1 NITTO DENKO CORPORATION Company Details
11.6.2 NITTO DENKO CORPORATION Business Overview
11.6.3 NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Introduction
11.6.4 NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.6.5 NITTO DENKO CORPORATION Recent Developments
11.7 Noven Pharmaceuticals
11.7.1 Noven Pharmaceuticals Company Details
11.7.2 Noven Pharmaceuticals Business Overview
11.7.3 Noven Pharmaceuticals Transdermal Patch Drug Delivery System Introduction
11.7.4 Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.7.5 Noven Pharmaceuticals Recent Developments
11.8 LTS Lohmann Therapie-Systeme
11.8.1 LTS Lohmann Therapie-Systeme Company Details
11.8.2 LTS Lohmann Therapie-Systeme Business Overview
11.8.3 LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Introduction
11.8.4 LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.8.5 LTS Lohmann Therapie-Systeme Recent Developments
11.9 Medherant
11.9.1 Medherant Company Details
11.9.2 Medherant Business Overview
11.9.3 Medherant Transdermal Patch Drug Delivery System Introduction
11.9.4 Medherant Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.9.5 Medherant Recent Developments
11.10 Corium
11.10.1 Corium Company Details
11.10.2 Corium Business Overview
11.10.3 Corium Transdermal Patch Drug Delivery System Introduction
11.10.4 Corium Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.10.5 Corium Recent Developments
11.11 Antares Pharma
11.11.1 Antares Pharma Company Details
11.11.2 Antares Pharma Business Overview
11.11.3 Antares Pharma Transdermal Patch Drug Delivery System Introduction
11.11.4 Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.11.5 Antares Pharma Recent Developments
11.12 Syntropharma
11.12.1 Syntropharma Company Details
11.12.2 Syntropharma Business Overview
11.12.3 Syntropharma Transdermal Patch Drug Delivery System Introduction
11.12.4 Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.12.5 Syntropharma Recent Developments
11.13 Teikoku Pharma
11.13.1 Teikoku Pharma Company Details
11.13.2 Teikoku Pharma Business Overview
11.13.3 Teikoku Pharma Transdermal Patch Drug Delivery System Introduction
11.13.4 Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.13.5 Teikoku Pharma Recent Developments
11.14 Mylan
11.14.1 Mylan Company Details
11.14.2 Mylan Business Overview
11.14.3 Mylan Transdermal Patch Drug Delivery System Introduction
11.14.4 Mylan Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.14.5 Mylan Recent Developments
11.15 Actavis
11.15.1 Actavis Company Details
11.15.2 Actavis Business Overview
11.15.3 Actavis Transdermal Patch Drug Delivery System Introduction
11.15.4 Actavis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.15.5 Actavis Recent Developments
11.16 Mundipharma
11.16.1 Mundipharma Company Details
11.16.2 Mundipharma Business Overview
11.16.3 Mundipharma Transdermal Patch Drug Delivery System Introduction
11.16.4 Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.16.5 Mundipharma Recent Developments
11.17 Henan Lingrui Pharmaceutical
11.17.1 Henan Lingrui Pharmaceutical Company Details
11.17.2 Henan Lingrui Pharmaceutical Business Overview
11.17.3 Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.17.4 Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.17.5 Henan Lingrui Pharmaceutical Recent Developments
11.18 Changzhou Siyao
11.18.1 Changzhou Siyao Company Details
11.18.2 Changzhou Siyao Business Overview
11.18.3 Changzhou Siyao Transdermal Patch Drug Delivery System Introduction
11.18.4 Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.18.5 Changzhou Siyao Recent Developments
11.19 Rfl Pharmaceutical
11.19.1 Rfl Pharmaceutical Company Details
11.19.2 Rfl Pharmaceutical Business Overview
11.19.3 Rfl Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.19.4 Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.19.5 Rfl Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Shunt Way
    Table 3. Key Players of Intercellular Lipid Structure Pathway
    Table 4. Key Players of Trans-cellular Pathway
    Table 5. Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Transdermal Patch Drug Delivery System Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Transdermal Patch Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Transdermal Patch Drug Delivery System Market Share by Region (2017-2022)
    Table 9. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Transdermal Patch Drug Delivery System Market Share by Region (2023-2028)
    Table 11. Transdermal Patch Drug Delivery System Market Trends
    Table 12. Transdermal Patch Drug Delivery System Market Drivers
    Table 13. Transdermal Patch Drug Delivery System Market Challenges
    Table 14. Transdermal Patch Drug Delivery System Market Restraints
    Table 15. Global Transdermal Patch Drug Delivery System Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Transdermal Patch Drug Delivery System Revenue Share by Players (2017-2022)
    Table 17. Global Top Transdermal Patch Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch Drug Delivery System as of 2021)
    Table 18. Ranking of Global Top Transdermal Patch Drug Delivery System Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Transdermal Patch Drug Delivery System Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Transdermal Patch Drug Delivery System Product Solution and Service
    Table 22. Date of Enter into Transdermal Patch Drug Delivery System Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Transdermal Patch Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2017-2022)
    Table 26. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2023-2028)
    Table 28. Global Transdermal Patch Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Transdermal Patch Drug Delivery System Revenue Share by Application (2017-2022)
    Table 30. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Transdermal Patch Drug Delivery System Revenue Share by Application (2023-2028)
    Table 32. North America Transdermal Patch Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Transdermal Patch Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Transdermal Patch Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Transdermal Patch Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Transdermal Patch Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Transdermal Patch Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Transdermal Patch Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Transdermal Patch Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Transdermal Patch Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Transdermal Patch Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Transdermal Patch Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Transdermal Patch Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Transdermal Patch Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Transdermal Patch Drug Delivery System Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Transdermal Patch Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Transdermal Patch Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Transdermal Patch Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Transdermal Patch Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Transdermal Patch Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Transdermal Patch Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Transdermal Patch Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Transdermal Patch Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Hisamitsu Pharmaceutical Company Details
    Table 63. Hisamitsu Pharmaceutical Business Overview
    Table 64. Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Product
    Table 65. Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 66. Hisamitsu Pharmaceutical Recent Developments
    Table 67. Novartis Company Details
    Table 68. Novartis Business Overview
    Table 69. Novartis Transdermal Patch Drug Delivery System Product
    Table 70. Novartis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 71. Novartis Recent Developments
    Table 72. ProSolus Company Details
    Table 73. ProSolus Business Overview
    Table 74. ProSolus Transdermal Patch Drug Delivery System Product
    Table 75. ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 76. ProSolus Recent Developments
    Table 77. Tapemark Company Details
    Table 78. Tapemark Business Overview
    Table 79. Tapemark Transdermal Patch Drug Delivery System Product
    Table 80. Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 81. Tapemark Recent Developments
    Table 82. Tesa Labtec Company Details
    Table 83. Tesa Labtec Business Overview
    Table 84. Tesa Labtec Transdermal Patch Drug Delivery System Product
    Table 85. Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 86. Tesa Labtec Recent Developments
    Table 87. NITTO DENKO CORPORATION Company Details
    Table 88. NITTO DENKO CORPORATION Business Overview
    Table 89. NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Product
    Table 90. NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 91. NITTO DENKO CORPORATION Recent Developments
    Table 92. Noven Pharmaceuticals Company Details
    Table 93. Noven Pharmaceuticals Business Overview
    Table 94. Noven Pharmaceuticals Transdermal Patch Drug Delivery System Product
    Table 95. Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 96. Noven Pharmaceuticals Recent Developments
    Table 97. LTS Lohmann Therapie-Systeme Company Details
    Table 98. LTS Lohmann Therapie-Systeme Business Overview
    Table 99. LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Product
    Table 100. LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 101. LTS Lohmann Therapie-Systeme Recent Developments
    Table 102. Medherant Company Details
    Table 103. Medherant Business Overview
    Table 104. Medherant Transdermal Patch Drug Delivery System Product
    Table 105. Medherant Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 106. Medherant Recent Developments
    Table 107. Corium Company Details
    Table 108. Corium Business Overview
    Table 109. Corium Transdermal Patch Drug Delivery System Product
    Table 110. Corium Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 111. Corium Recent Developments
    Table 112. Antares Pharma Company Details
    Table 113. Antares Pharma Business Overview
    Table 114. Antares Pharma Transdermal Patch Drug Delivery System Product
    Table 115. Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 116. Antares Pharma Recent Developments
    Table 117. Syntropharma Company Details
    Table 118. Syntropharma Business Overview
    Table 119. Syntropharma Transdermal Patch Drug Delivery System Product
    Table 120. Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 121. Syntropharma Recent Developments
    Table 122. Teikoku Pharma Company Details
    Table 123. Teikoku Pharma Business Overview
    Table 124. Teikoku Pharma Transdermal Patch Drug Delivery System Product
    Table 125. Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 126. Teikoku Pharma Recent Developments
    Table 127. Mylan Company Details
    Table 128. Mylan Business Overview
    Table 129. Mylan Transdermal Patch Drug Delivery System Product
    Table 130. Mylan Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 131. Mylan Recent Developments
    Table 132. Actavis Company Details
    Table 133. Actavis Business Overview
    Table 134. Actavis Transdermal Patch Drug Delivery System Product
    Table 135. Actavis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 136. Actavis Recent Developments
    Table 137. Mundipharma Company Details
    Table 138. Mundipharma Business Overview
    Table 139. Mundipharma Transdermal Patch Drug Delivery System Product
    Table 140. Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 141. Mundipharma Recent Developments
    Table 142. Henan Lingrui Pharmaceutical Company Details
    Table 143. Henan Lingrui Pharmaceutical Business Overview
    Table 144. Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Product
    Table 145. Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 146. Henan Lingrui Pharmaceutical Recent Developments
    Table 147. Changzhou Siyao Company Details
    Table 148. Changzhou Siyao Business Overview
    Table 149. Changzhou Siyao Transdermal Patch Drug Delivery System Product
    Table 150. Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 151. Changzhou Siyao Recent Developments
    Table 152. Rfl Pharmaceutical Company Details
    Table 153. Rfl Pharmaceutical Business Overview
    Table 154. Rfl Pharmaceutical Transdermal Patch Drug Delivery System Product
    Table 155. Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
    Table 156. Rfl Pharmaceutical Recent Developments
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Transdermal Patch Drug Delivery System Market Share by Type: 2021 VS 2028
    Figure 2. Shunt Way Features
    Figure 3. Intercellular Lipid Structure Pathway Features
    Figure 4. Trans-cellular Pathway Features
    Figure 5. Global Transdermal Patch Drug Delivery System Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Home Care Case Studies
    Figure 9. Other Case Studies
    Figure 10. Transdermal Patch Drug Delivery System Report Years Considered
    Figure 11. Global Transdermal Patch Drug Delivery System Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Transdermal Patch Drug Delivery System Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Transdermal Patch Drug Delivery System Market Share by Region: 2021 VS 2028
    Figure 14. Global Transdermal Patch Drug Delivery System Market Share by Players in 2021
    Figure 15. Global Top Transdermal Patch Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch Drug Delivery System as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Transdermal Patch Drug Delivery System Revenue in 2021
    Figure 17. North America Transdermal Patch Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Transdermal Patch Drug Delivery System Market Size Market Share by Type (2017-2028)
    Figure 19. North America Transdermal Patch Drug Delivery System Market Size Market Share by Application (2017-2028)
    Figure 20. North America Transdermal Patch Drug Delivery System Market Size Share by Country (2017-2028)
    Figure 21. United States Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Transdermal Patch Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Transdermal Patch Drug Delivery System Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Transdermal Patch Drug Delivery System Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Transdermal Patch Drug Delivery System Market Size Share by Country (2017-2028)
    Figure 27. Germany Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Transdermal Patch Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Transdermal Patch Drug Delivery System Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Transdermal Patch Drug Delivery System Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Transdermal Patch Drug Delivery System Market Size Share by Region (2017-2028)
    Figure 37. China Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Transdermal Patch Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Transdermal Patch Drug Delivery System Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Transdermal Patch Drug Delivery System Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Transdermal Patch Drug Delivery System Market Size Share by Country (2017-2028)
    Figure 47. Mexico Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Transdermal Patch Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Transdermal Patch Drug Delivery System Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Transdermal Patch Drug Delivery System Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Transdermal Patch Drug Delivery System Market Size Share by Country (2017-2028)
    Figure 53. Turkey Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Hisamitsu Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 58. ProSolus Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 59. Tapemark Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 60. Tesa Labtec Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 61. NITTO DENKO CORPORATION Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 62. Noven Pharmaceuticals Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 63. LTS Lohmann Therapie-Systeme Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 64. Medherant Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 65. Corium Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 66. Antares Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 67. Syntropharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 68. Teikoku Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 69. Mylan Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 70. Actavis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 71. Mundipharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 72. Henan Lingrui Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 73. Changzhou Siyao Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 74. Rfl Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Marine Bio Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Marine Bio Products Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-34E5025
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

Global Potassium Tert Butoxide Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Potassium Tert-Butoxide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-25B5115
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

Global Medical Specialty Enzymes Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
Global Medical Specialty Enzymes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-13Z12247
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

China Aptamers Market Report Forecast 2021 2027
Global Aptamers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-07
Fri Sep 23 00:00:00 UTC 2022

Add to Cart